Catalysts for $MNKD
17 tracked
Nov 4, 2026
earnings
MANNKIND CORP earnings
MANNKIND CORP
→
May 7, 2026
earnings
MANNKIND CORP earnings
MANNKIND CORP
→
Apr 22, 2026
drug shortage
Furosemide Injection shortage — Hospira, Inc., a Pfizer Company
MANNKIND CORP
→
Jan 23, 2026
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Feb 3, 2023
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Oct 25, 2018
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Apr 24, 2018
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Sep 29, 2017
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Apr 7, 2016
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Feb 17, 2016
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Sep 16, 2015
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Jun 24, 2015
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Jun 24, 2015
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Apr 20, 2015
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Apr 17, 2015
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Mar 12, 2015
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→
Jun 27, 2014
approval
AFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approval
insulin human
→